Market Research Logo

Global E-Prescribing Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

Global E-Prescribing Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

The global e-prescribing market is expected to grow with the CAGR of approximately 21.2% during the forecast period. The market has been driven due to large number of factors such as implementation of EHR with E-Prescribing system, favorable government support to develop healthcare infrastructure, growing focus on patient convenience and decreasing medication errors and high focus on declining healthcare cost. Approximately, half of all healthcare costs come from hospital expenditure: around 30% from hospital inpatient and around 19% from hospital outpatient. Physicians hold for approx. 30% and prescription drugs approx. 17%. Thus, to reduce such cost e-prescribing is a better tool as it declines manual work and connects medical professionals with each other. Although, there are some hurdles in the market such as patient privacy & security issues and lack of high speed broadband services. Growing demand in emerging countries and increasing demand among physicians are offering better opportunity for the market growth in near future. However, lack of skilled professionals and high cost of the system are some major challenges in the market. Geographically, Europe occupies major share in e-prescribing market. The reason for its dominance is growing burden to reduce healthcare cost coupled with the growing chronic disease and aging population in the region. North America and Asia Pacific is also expected to grow high in near future with the growing government support to create better healthcare infrastructure. Moreover, the presence of major players such as IBM, GE Healthcare, Cerner Corporation, Athena Health Inc., QuadraMed etc. are offering high scope for more innovations in the market.

The global E-Prescribing market has been segmented on the basis of delivery model, end user and product. According to Product, the market is further categorized into solutions and services. Among Product segment, the solutions held major share in 2015. The increasing adoption of e-prescribing solutions coupled with government support by incentive programs. According to end user, the market is further categorized into hospitals, physicians and clinics. Among end user segment, hospitals held major share with the extensive demand for e-prescribing solutions in the hospitals of Europe and U.S. In addition, the Patient Protection and Affordable Care Act in the United States have attributed to the reorganization of Medicare, private insurance and Medicaid systems. For physicians, the CMS incentive program compensates physicians for utilizing EHR (Electronic Health Records), which is helpful to increase the use of such solutions among physicians. According to delivery model, the market is further categorized into Cloud based, On-premise and Web-based models. Among delivery model, web based and cloud based segment together held major share. It has been led due to growing demand for cloud-based solutions in order to increase the convenience to send patient records from distant locations and which ultimately develop workflow efficiency. In addition, it is also helpful to connect with IT staff in order to focus on highly critical tasks which increasing cost-efficiency and productivity of the organization.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL E-PRESCRIBING MARKET: EVOLUTION & TRANSITION
2.2. INDUSTRY STRUCTURE
2.3. TOTAL MARKET ANALYSIS
2.3.1. TOP 5 FINDINGS
2.3.2. TOP 5 OPPORTUNITY MARKETS
2.3.3. TOP 5 COMPANIES
2.3.4. TOP 3 COMPETITIVE STRATEGIES
2.4. ESTIMATION ANALYSIS
2.5. STRATEGIC ANALYSIS
2.5.1. INVESTMENT VS. ADOPTION MODEL
2.5.2. 360 DEGREE INDUSTRY ANALYSIS
2.5.3. PORTERS 5 FORCE MODEL
2.5.4. SEE-SAW ANALYSIS
2.5.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.6. COMPETITIVE ANALYSIS
2.6.1. MARKET SHARE ANALYSIS
2.6.2. TOP COMPANY ANALYSIS
2.7. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.7.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.7.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.7.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. IMPLEMENTATION OF EHR WITH E-PRESCRIBING SYSTEM
3.1.2. GROWING FOCUS ON PATIENT CONVENIENCE AND DECREASING MEDICATION ERRORS.
3.1.3. FAVORABLE GOVERNMENT SUPPORT TO DEVELOP HEALTHCARE INFRASTRUCTURE
3.1.4. HIGH FOCUS ON DECLINING HEALTHCARE COST
3.2. MARKET RESTRAINTS
3.2.1. PATIENT PRIVACY & SECURITY ISSUES
3.2.2. LACK OF HIGH SPEED BROADBAND SERVICES
3.3. MARKET OPPORTUNITIES
3.3.1. GROWING DEMAND IN EMERGING COUNTRIES
3.3.2. INCREASING DEMAND AMONG PHYSICIANS
3.4. MARKET CHALLENGES
3.4.1. LACK OF SKILLED PROFESSIONALS
3.4.2. HIGH COST OF THE SYSTEM.
4. MARKET SEGMENTATION
4.1. GLOBAL E-PRESCRIBING MARKET BY DELIVERY MODEL
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION BY COMPONENT 2014-2023 ($ MILLION)
4.1.5.1. GLOBAL E-PRESCRIBING MARKET BY CLOUD BASED
4.1.5.1.1. APPLICATION
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. GLOBAL E-PRESCRIBING MARKET BY ON-PREMISE
4.1.5.2.1. APPLICATION
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.1.5.3. GLOBAL E-PRESCRIBING MARKET BY WEB BASED
4.1.5.3.1. APPLICATION
4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.5. KEY CONCLUSIONS
4.2. GLOBAL E-PRESCRIBING MARKET BY END USER
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION BY END USER 2014-2023 ($ MILLION)
4.2.5.1. GLOBAL E-PRESCRIBING MARKET BY HOSPITALS
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL E-PRESCRIBING MARKET BY PHYSICIANS
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL E-PRESCRIBING MARKET BY CLINICS
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.3. GLOBAL E-PRESCRIBING MARKET BY PRODUCT
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION BY PRODUCT 2014-2023 ($ MILLION)
4.3.5.1. GLOBAL E-PRESCRIBING MARKET BY SOLUTIONS
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL E-PRESCRIBING MARKET BY SERVICES
4.3.5.3. APPLICATION
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.4. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF M&A
5.1.2. LIST OF JV
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL E-PRESCRIBING MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL END USER ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY END USER ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY END USER ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY END USER ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. ATHENA HEALTH INC.
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
7.3. CERNER CORPORATION
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. DRFIRST
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. DUO SECURITY
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
7.6. ECLINICAL WORKS
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7. E-MDS
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
7.8. GE HEALTHCARE
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS
7.9. HENRY SCHEIN INC.
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.9.6. STRATEGIC ANALYSIS
7.10. IBM
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. IMEDX INC.
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. INFOSYS
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. PRACTICE FUSION
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. QUADRAMED CORPORATION
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. RELAY HEALTH LLC
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL E-PRESCRIBING MARKET BY DELIVERY MODEL ($ MILLION)
GLOBAL CLOUD-BASED E-PRESCRIBING BY GEOGRAPHY ($ MILLION)
GLOBAL ON-PREMISE E-PRESCRIBING BY GEOGRAPHY ($ MILLION)
GLOBAL WEB-BASED E-PRESCRIBING BY GEOGRAPHY ($ MILLION)
GLOBAL E-PRESCRIBING MARKET BY END USER ($ MILLION)
GLOBAL HOSPITALS E-PRESCRIBING BY GEOGRAPHY ($ MILLION)
GLOBAL PHYSICIANS E-PRESCRIBING BY GEOGRAPHY ($ MILLION)
GLOBAL CLINICS E-PRESCRIBING BY GEOGRAPHY ($ MILLION)
GLOBAL E-PRESCRIBING MARKET BY PRODUCT ($ MILLION)
GLOBAL E-PRESCRIBING SOLUTIONS BY GEOGRAPHY ($ MILLION)
GLOBAL E-PRESCRIBING SERVICES BY GEOGRAPHY ($ MILLION)
NORTH AMERICA E-PRESCRIBING MARKET ($ MILLION)
EUROPE E-PRESCRIBING MARKET ($ MILLION)
ASIA PACIFIC E-PRESCRIBING MARKET ($ MILLION)
REST OF THE WORLD E-PRESCRIBING MARKET ($ MILLION)
LIST OF FIGURES
GLOBAL E-PRESCRIBING MARKET BY CLOUD-BASED ($ MILLION)
GLOBAL E-PRESCRIBING MARKET BY ON-PREMISE ($ MILLION)
GLOBAL E-PRESCRIBING MARKET BY WEB-BASED ($ MILLION)
GLOBAL E-PRESCRIBING MARKET BY HOSPITALS ($ MILLION)
GLOBAL E-PRESCRIBING MARKET BY PHYSICIANS ($ MILLION)
GLOBAL E-PRESCRIBING MARKET BY CLINICS ($ MILLION)
GLOBAL E-PRESCRIBING MARKET BY SOLUTIONS ($ MILLION)
GLOBAL E-PRESCRIBING MARKET BY SERVICES ($ MILLION)
UNITED STATES (U.S.) E-PRESCRIBING MARKET ($ MILLION)
CANADA E-PRESCRIBING MARKET ($ MILLION)
UNITED KINGDOM (UK) E-PRESCRIBING MARKET ($ MILLION)
FRANCE E-PRESCRIBING MARKET ($ MILLION)
GERMANY E-PRESCRIBING MARKET ($ MILLION)
SPAIN E-PRESCRIBING MARKET ($ MILLION)
ROE E-PRESCRIBING MARKET ($ MILLION)
INDIA E-PRESCRIBING MARKET ($ MILLION)
CHINA E-PRESCRIBING MARKET ($ MILLION)
JAPAN E-PRESCRIBING MARKET ($ MILLION)
AUSTRALIA E-PRESCRIBING MARKET ($ MILLION)
ROAPAC E-PRESCRIBING MARKET ($ MILLION)
LATIN AMERICA E-PRESCRIBING MARKET ($ MILLION)
MENA E-PRESCRIBING MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report